| Comparative review of the carbapenems GG Zhanel, R Wiebe, L Dilay, K Thomson, E Rubinstein, DJ Hoban, ... Drugs 67, 1027-1052, 2007 | 894 | 2007 |
| A critical review of the fluoroquinolones: focus on respiratory tract infections GG Zhanel, K Ennis, L Vercaigne, A Walkty, AS Gin, J Embil, H Smith, ... Drugs 62, 13-59, 2002 | 572 | 2002 |
| Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system CY Turenne, SE Sanche, DJ Hoban, JA Karlowsky, AM Kabani Journal of clinical microbiology 37 (6), 1846-1851, 1999 | 526 | 1999 |
| Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination GG Zhanel, CD Lawson, H Adam, F Schweizer, S Zelenitsky, ... Drugs 73, 159-177, 2013 | 508 | 2013 |
| Worldwide Prevalence of Antimicrobial Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY … DJ Hoban, GV Doern, AC Fluit, M Roussel-Delvallez, RN Jones Clinical Infectious Diseases 32 (Supplement_2), S81-S93, 2001 | 502 | 2001 |
| Clinical pharmacokinetics of vancomycin GR Matzke, GG Zhanel, DRP Guay Clinical pharmacokinetics 11, 257-282, 1986 | 471 | 1986 |
| Fluoroquinolone-associated tendinopathy: a critical review of the literature Y Khaliq, GG Zhanel Clinical Infectious Diseases 36 (11), 1404-1410, 2003 | 436 | 2003 |
| Review of macrolides and ketolides: focus on respiratory tract infections GG Zhanel, M Dueck, DJ Hoban, LM Vercaigne, JM Embil, AS Gin, ... Drugs 61, 443-498, 2001 | 436 | 2001 |
| Clinical practice guidelines for hospital‐acquired pneumonia and ventilator‐associated pneumonia in adults C Rotstein, G Evans, A Born, R Grossman, RB Light, S Magder, ... Canadian Journal of Infectious Diseases and Medical Microbiology 19 (1), 19-53, 2008 | 435 | 2008 |
| The glycylcyclines: a comparative review with the tetracyclines GG Zhanel, K Homenuik, K Nichol, A Noreddin, L Vercaigne, J Embil, ... Drugs 64, 63-88, 2004 | 435 | 2004 |
| Antimicrobial treatment in diabetic women with asymptomatic bacteriuria GKM Harding, GG Zhanel, LE Nicolle, M Cheang New England Journal of Medicine 347 (20), 1576-1583, 2002 | 412 | 2002 |
| Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines JP Lynch III, GG Zhanel Current opinion in pulmonary medicine 16 (3), 217-225, 2010 | 401 | 2010 |
| Imipenem–relebactam and meropenem–vaborbactam: two novel carbapenem-β-lactamase inhibitor combinations GG Zhanel, CK Lawrence, H Adam, F Schweizer, S Zelenitsky, M Zhanel, ... Drugs 78, 65-98, 2018 | 386 | 2018 |
| Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention JP Lynch, GG Zhanel Seminars in respiratory and critical care medicine 30 (02), 189-209, 2009 | 378 | 2009 |
| Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) GG Zhanel, TL Hisanaga, NM Laing, MR DeCorby, KA Nichol, ... International journal of antimicrobial agents 27 (6), 468-475, 2006 | 374 | 2006 |
| Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006 GG Zhanel, M DeCorby, N Laing, B Weshnoweski, R Vashisht, F Tailor, ... Antimicrobial agents and chemotherapy 52 (4), 1430-1437, 2008 | 373 | 2008 |
| New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin GG Zhanel, D Calic, F Schweizer, S Zelenitsky, H Adam, ... Drugs 70, 859-886, 2010 | 369 | 2010 |
| Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli GG Zhanel, P Chung, H Adam, S Zelenitsky, A Denisuik, F Schweizer, ... Drugs 74, 31-51, 2014 | 368 | 2014 |
| Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004 JR Johnson, M Menard, B Johnston, MA Kuskowski, K Nichol, GG Zhanel Antimicrobial agents and chemotherapy 53 (7), 2733-2739, 2009 | 367 | 2009 |
| Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli GG Zhanel, AR Golden, S Zelenitsky, K Wiebe, CK Lawrence, HJ Adam, ... Drugs 79, 271-289, 2019 | 366 | 2019 |
